Oberweis Asset Management »

Evolus shares owned by Oberweis Asset Management

Quarter-by-quarter ownership of Evolus (EOLS) shares owned by Oberweis Asset Management from 13F filings

Historical chart of Oberweis Asset Management investment in Evolus

Tip: Access up to 7 years of quarterly data

All positions including Evolus held by Oberweis Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Evolus by Oberweis Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.9M 371k 10.53

More positions owned by Oberweis Asset Management

Constellium Se cl a (CSTM)
Axcelis Technologies (ACLS)
Aehr Test Systems (AEHR)
Alphatec Holdings (ATEC)
Weatherford Intl Ordf (WFRD)
Amphastar Pharmaceuticals (AMPH)
Veracyte (VCYT)
Applied Optoelectronics (AAOI)
Transmedics Group (TMDX)
Perion Network (PERI)
Universal Display Corporation (OLED)
Adma Biologics (ADMA)
Camtek (CAMT)
Vertiv Holdings Llc vertiv holdings (VRT)
Axonics Modulation Technolog (AXNX)

View all positions for Oberweis Asset Management

Top funds holding Evolus

Perceptive Advisors
Tang Capital Management
Vanguard Group
Nantahala Capital Management
Dr. Jeffrey R. Jay, M.D.
Deutsche Bank Aktiengesellschaft
Caligan Partners
Millennium Management
Rice Hall James & Associates
D. E. Shaw & Co
UBS Group
AWH Capital
Marshall Wace
Soros Fund Management
Oberweis Asset Management

View all funds holding Evolus